Belite Bio (BLTE) Capital Expenditures (2020 - 2022)

Belite Bio (BLTE) posted quarterly Capital Expenditures of $232000.0 for Q4 2024.

Analysis

Belite Bio (BLTE) Capital Expenditures (2020 - 2022) Analysis & Trends

Belite Bio's Capital Expenditures history runs 1 years deep, the most recent figure standing at $232000.0 for Q4 2024.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Capital Expenditures (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn	112.20 Mn
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn	240.20 Mn
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn	-
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn	37.00 Mn
5	Revolution Medicines	44.33 Bn	44.33 Bn	-	2.29 Mn
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn	25.02 Mn
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn	34.68 Mn
8	Royalty Pharma	28.45 Bn	27.61 Bn	-	251.02 Mn
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	6.26 Mn
10	Belite Bio	6.44 Bn	6.44 Bn	-	-

Historic Data

Download Data